|
1
|
Al-Asmari AK and Al-Saif AA: Scorpion
sting syndrome in a general hospital in Saudi Arabia. Saudi Med J.
25:64–70. 2004.PubMed/NCBI
|
|
2
|
Mahaba HM: ElS ayed SA: Scorpion sting: Is
it a health problem in Saudi Arabia? Evaluation of management of
820 cases. Saudi Med J. 17:15–21. 1996.
|
|
3
|
Mahaba HM: Scorpion sting syndrome:
Epidemiology clinical presentations and management of 2240 cases.
East Mediterr Health J. 3:82–89. 1997.
|
|
4
|
Simard MJ and Watt DD: Venoms and toxins.
The Biology of Scorpions. Polis GA: X:(Yth). (Redwood City, CA).
Stanford University Press. 414–444. 1990.
|
|
5
|
Al Asmari AK, Khan HA and Manthiri RA: AlY
ahya KM and Al Otaibi KE: Effects of Echis pyramidum snake
venom on hepatic and renal antioxidant enzymes and lipid
peroxidation in rats. J Biochem Mol Toxicol. 28:407–412. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al Asmari AK, Al Zahrani AG, Al Jowhary S
and Arshaduddin M: Clinical aspects and frequency of scorpion
stings in the Riyadh region of Saudi Arabia. Saudi Med J.
33:852–858. 2012.PubMed/NCBI
|
|
7
|
Ozkan O and Filazi A: The determination of
acute lethal dose-50 (LD50) levels of venom in mice obtained by
different methods from scorpions, Androctonus crassicauda
(Oliver 1807). Turkiye Parazitol Derg. 28:50–53. 2004.
|
|
8
|
Bawaskar HS and Bawaskar PH: Scorpion
sting: Update. J Assoc Physicians India. 60:46–55. 2012.PubMed/NCBI
|
|
9
|
Petricevich VL: Effect of Tityus
serrulatus venom on cytokine production and the activity of
murine macrophages. Mediators Inflamm. 11:23–31. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rochat H, Bernard P and Couraud F:
Scorpion toxins: Chemistry and mode of action. Advances in
Cytopharmacology, Neurotoxins Tools in Neurobiology. Ceccarelli B
and Clementi F: 3:(Yth). (New York, NY). Raven. 325–334. 1979.
|
|
11
|
Andreotti N, Jouirou B, Mouhat S, Mouhat L
and Sabatier JM: Therapeutic value of peptides from animal Venoms.
Amino Acids, Peptides and Proteins, Comprehensive Natural Products
II Chemistry and Biology. Mander L and Lui HD: X:(Yth). (Oxford).
Elsevier. 287–303. 2010.
|
|
12
|
Ahn MY, Ryu KS, Lee YW and Kim YS:
Cytotoxicity and L-amino acid oxidase activity of crude insect
drugs. Arch Pharm Res. 23:477–481. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Z, Hong W, Zeng Z, Wu Y, Hu K, Tian
X, Li W and Cao Z: Mucroporin-M1 inhibits hepatitis B virus
replication by activating the mitogen-activated protein kinase
(MAPK) pathway and down-regulating HNF4-α in vitro and in
vivo. J Biol Chem. 287:30181–30190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Cao L, Zhong M, Zhang Y, Han C, Li
Q, Yang J, Zhou D, Shi W, He B, et al: Anti-HIV-1 activity of a new
scorpion venom peptide derivative Kn2-7. PLoS One. 7:e349472012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
El-Ghlban S, Kasai T, Shigehiro T, Yin HX,
Sekhar S, Ida M, Sanchez A, Mizutani A, Kudoh T, Murakami H and
Seno M: Chlorotoxin-Fc fusion inhibits release of MMP-2 from
pancreatic cancer cells. Biomed Res Int. 2014:1526592014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta SD and Gomes A, Debnath A, Saha A
and Gomes A: Apoptosis induction in human leukemic cells by a novel
protein Bengalin, isolated from Indian black scorpion venom,
Through mitochondrial pathway and inhibition of heat shock
proteins. Chem Biol Interact. 183:293–303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding J, Chua PJ, Bay BH and
Gopalakrishnakone P: Scorpion venoms as a potential source of novel
cancer therapeutic compounds. Exp Biol Med (Maywood). 239:387–393.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Colorectal Cancer Facts & Figures
2014-2016. Atlanta: American Cancer Society Inc. 2014.
|
|
19
|
Breast Cancer Facts & Figures
2013-2014. Atlanta: American Cancer Society, Inc. 2013.
|
|
20
|
Mosli MH and Al-Ahwal MS: Colorectal
cancer in the Kingdom of Saudi Arabia: Need for screening. Asian
Pac J Cancer Prev. 13:3809–3813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Alghamdi IG, Hussain II, Alghamdi MS and
El-Sheemy MA: The incidence rate of female breast cancer in Saudi
Arabia. An observational descriptive epidemiological analysis of
data from Saudi Cancer Registry 2001-2008. Breast Cancer (Dove Med
Press). 5:103–109. 2013.PubMed/NCBI
|
|
22
|
Folkman J: Angiogenesis: I nitiation and
control. Ann N Y Acad Sci. 401:212–227. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis. An imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sato H, Takino T, Okada Y, Cao J,
Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase
expressed on the surface of invasive tumour cells. Nature.
370:61–65. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Itoh Y and Seiki M: MT1-MMP: A potent
modifier of pericellular microenvironment. J Cell Physiol. 206:1–8.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gross J and Lapiere CM: Collagenolytic
activity in amphibian tissues: A tissue culture assay. Proc Natl
Acad Sci USA. 48:1014–1022. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gross J and Nagai Y: Specific degradation
of the collagen molecule by tadpole collagenolytic enzyme. Proc
Natl Acad Sci USA. 54:1197–1204. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Van Lint P and Libert C: Chemokine and
cytokine processing by matrix metalloproteinases and its effect on
leukocyte migration and inflammation. J Leukoc Biol. 82:1375–1381.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deshane J, Garner CC and Sontheimer H:
Chlorotoxin inhibits glioma cell invasion via matrix
metalloproteinase-2. J Biol Chem. 278:4135–4144. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soroceanu L, Gillespie Y, Khazaeli MB and
Sontheimer H: Use of chlorotoxin for targeting of primary brain
tumors. Cancer Res. 58:4871–4879. 1998.PubMed/NCBI
|
|
31
|
Lyons SA, O'Neal J and Sontheimer H:
Chlorotoxin, a scorpion-derived peptide, specifically binds to
gliomas and tumors of neuroectodermal origin. Glia. 39:162–173.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qin C, He B, Dai W, Zhang H, Wang X, Wang
J, Zhang X, Wang G, Yin L and Zhang Q: Inhibition of metastatic
tumor growth and metastasis via targeting metastatic breast cancer
by chlorotoxin-modified liposomes. Mol Pharm. 11:3233–3241. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zucker S and Vacirca J: Role of matrix
metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis
Rev. 23:101–117. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vermeulen SJ, Chen TR, Speleman F and
Nollet F: VanR oy FM and Mareel MM: Did the four human cancer cell
lines DLD-1, HCT-15, HCT-8 and HRT-18 originate from one and the
same patient? Cancer Genet Cytogenet. 107:76–79. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Crowley-Weber CL, Payne CM, Gleason-Guzman
M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K,
Bernstein C, Craven M, et al: Development and molecular
characterization of HCT-116 cell lines resistant to the tumor
promoter and multiple stress-inducer, deoxycholate. Carcinogenesis.
23:2063–2080. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cailleau R, Young R, Olivé M and Reeves WJ
Jr: Breast tumor cell lines from pleural effusions. J Natl Cancer
Inst. 53:661–674. 1974.PubMed/NCBI
|
|
37
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat
Protoc. 1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Omran MAA: In vitro anticancer
effect of scorpion Leiurus quinquestriatus and Egyptian
cobra venom on human breast and prostate cancer cell lines. Res J
Med Sci. 3:66–86. 2003.
|
|
39
|
Fu YJ, Yin LT, Liang AH, Zhang CF, Wang W,
Chai BF, Yang JY and Fan XJ: Therapeutic potential of
chlorotoxin-like neurotoxin from the Chinese scorpion for human
gliomas. Neurosci Lett. 412:62–67. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao F, Li H, Chen YD, Yu XN, Wang R and
Chen XL: Upregulation of PTEN involved in scorpion venom-induced
apoptosis in a lymphoma cell line. Leuk Lymphoma. 50:633–641. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Islam M, Datta J, Lang JC and Teknos TN:
Down regulation of RhoC by microRNA-138 results in de-activation of
FAK, Src and Erk1/2 signaling pathway in head and neck squamous
cell carcinoma. Oral Oncol. 50:448–456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Islam M, Sharma S, Kumar B and Teknos TN:
Atorvastatin inhibits RhoC function and limits head and neck cancer
metastasis. Oral Oncol. 49:778–786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schlaepfer DD and Mitra SK: Multiple
connections link FAK to cell motility and invasion. Curr Opin Genet
Dev. 14:92–101. 2004. View Article : Google Scholar : PubMed/NCBI
|
